Figure 1From: In vivo TSPO imaging in patients with multiple sclerosis: a brain PET study with [18F]FEDAA1106 Comparison of BP ND (left) and VT (right) of [18 F] FEDAA1106 in whole gray matter among MS patients. Six without treatment (MS(−)), three with treatment (MS(+)), and five healthy controls (HC). There were no significant differences of BPND or VT.Back to article page